HIV Therapy: Prescription trends, Markets and Unmet Needs

Questions: Discounts, Updates etc.

Price: $15,200.00

Publication Date: 2007-10-08

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Despite several developments in efforts to tackle the spread of HIV, the total number of people living with HIV has continued to increase across the 6MM. However, significant advances in HIV disease understanding, treatment and management mean that the outlook for patients has considerably improved.


Scope

  • Current epidemiology of HIV in the six major markets, including prevalence, diagnosis rates and patients split by line of therapy and drug regimens
  • A detailed examination of the patient numbers on each line of therapy, their drug regimens and preferences
  • Evaluation of the factors determining prescription choices and their respective level of influence
  • An assessment of the perception of new products in development and of key unmet needs within HIV


    • Report Highlights
    In the US and M5EU the total number of people living with HIV is continuing to increase. According to Datamonitor's physician survey, the total number of diagnosed patients across the 6MM is 1.1 million, of which 18% are treatment-na�ve and approx. 800.000 are currently receiving therapy

    The complexity of HAART begins to increase as patients progress to later stages of therapy, with regimens consisting of up to 6 different drugs. Treatment also becomes much more individualized: Datamonitor's research shows that the top 5 most popular regimens selected by physicians account for only 13% of patients in salvage therapy

    Prescription choice is largely driven by patient and product-specific qualities, but the influence of these issues varies according to line of therapy. Efficacy and resistance profile exert an increasing influence as the patient becomes more treatment-experienced.


    Reasons to Purchase

  • Identify the key factors underlying prescription choice for treatment of HIV
  • Examine the current unmet needs in the HIV market and identify opportunities for new product development
  • Enhance your commercial positioning through an improved understanding of the HIV market dynamics

    • Table of Contents

    Other users found this report page using the following search terms: hiv ccr5 integrase haart hiv therapy trends uk market unmet prescription needs treatment prescriptions

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.